University of California, Santa Cruz
| Award Total: $4,361,264 |
# of Grants: 12 |
Investigators
Grants
|
| Determining How the Intratumoral Environment Confers Stemness in Lung Cancer |
2019 (Cycle 30) |
$166,350 |
| Cancer |
Dissertation Awards |
|
| Defining regulators of hematopoietic stem cell self-renewal to prevent and treat blood cancers. |
2019 (Cycle 30) |
$166,350 |
| Cancer |
Dissertation Awards |
|
| Understanding how perinatal nicotine exposure influences immune establishment and function for life |
2019 (Cycle 30) |
$166,350 |
| Pulmonary Disease |
Dissertation Awards |
|
| Impact of splicing factor mutations in the context of tobacco exposure in lung cancer |
2019 (Cycle 29) |
$736,710 |
| Cancer |
New Investigator Awards |
|
| Investigating the Roles of Stromal AR in Prostate Cancer Progression |
2019 (Cycle 29) |
$203,280 |
| Cancer |
Postdoctoral Fellowship Awards |
|
| The Impact of Trade Agreements on Domestic Health Regulation |
2015 (Cycle 24) |
$29,293 |
| Industry Influence/Policy |
Dissertation Awards |
|
| Lung cancer cell response to Cdk4/6 inhibition |
2019 (Cycle 28) |
$1,047,491 |
| Cancer |
High Impact Research Project Award |
|
| Natural Products for the Treatment of Never Smoker Lung Cancer |
2018 (Cycle 27) |
$935,133 |
| Environmental Exposure/Toxicology |
High Impact Research Project Award |
|
| Determining a role for long noncoding RNAs in smoke-induced COPD |
2018 (Cycle 27) |
$519,043 |
| Pulmonary Disease |
High Impact Pilot Award |
|
| Targeted Degradation of Proliferative E2F in Nicotine-Induced Lung Cancers |
2018 (Cycle 27) |
$134,659 |
| Cancer |
Dissertation Awards |
|
| Structural Mechanism of Rb Inactivation in Lung Adenocarcinoma |
2018 (Cycle 27) |
$134,659 |
| Cancer |
Dissertation Awards |
|
| Asymmetric Synthesis of (-)-Podophyllotoxin |
1993 (Cycle 2) |
$121,946 |
| Cancer |
Research Project Awards |
